Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2018

01.02.2018 | Original Article

Cytomegalovirus infection and steroid-refractory inflammatory bowel disease: possible relationship from an updated meta-analysis

verfasst von: Chen-Chen Liu, Shusheng Ji, Yuanyuan Ding, Lili Zhou, Xiangyu Liu, Wen Li

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

Many studies have suggested Cytomegalovirus infection might be implicated in steroid-refractory inflammatory bowel disease (IBD), in which situation management is extremely difficult. CMV infection being a potential cause of IBD have drawn great attention of clinicians, with insufficient evidence to reach conclusions.

Methods

We conduct this meta-analysis to explore the association of CMV infection and steroid-refractory IBD by collecting relevant articles. Literature collections were conducted by searching PubMed, EMBASE, and the cochrane library databases. Pooled risk ratios (RR) with corresponding 95% confidence intervals (CIs) were calculated to estimate the strength of the link between CMV infection and steroid resistance in IBD using Stata 12.0.

Results

Thirteen eligible studies with a total of 1119 patients conducted in eight countries were included. The steroid resistance rate in the CMV (+) groups was 62.8%, while that in the CMV (−) groups was 29.2%. The pooled RR of steroid resistance rate in CMV (+) groups compared to CMV (−) groups was 2.343 (95% CI 1.715–3.202, P = 0.0000). Due to marginal heterogeneity across studies (I2 = 77.6%), the random effects model was used. Subgroup analysis based on geographic differences did not alter the overall positive association between CMV infection and steroid resistance in IBD. There is no significant publication bias observed based on the funnel plot and Begg’s test.

Conclusions

This meta-analysis disclosed 2.34 fold increased risk of progressing into steroid-refractory IBD in CMV (+) group compared with the CMV (−) group, indicating that CMV infection might be a plausible cause of steroid-refractory IBD.
Literatur
2.
Zurück zum Zitat Sands BE, Grabert S (2009) Epidemiology of inflammatory bowel disease and overview of pathogenesis. Med Health R I 92:73–77PubMed Sands BE, Grabert S (2009) Epidemiology of inflammatory bowel disease and overview of pathogenesis. Med Health R I 92:73–77PubMed
3.
Zurück zum Zitat Al-Zafiri R, Gologan AZ, Galiatsatos P et al (2012) Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol 8:230–239 Al-Zafiri R, Gologan AZ, Galiatsatos P et al (2012) Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol 8:230–239
6.
Zurück zum Zitat Powell RD, Warner NE, Levine RS et al (1961) Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med 30:334–340CrossRefPubMed Powell RD, Warner NE, Levine RS et al (1961) Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med 30:334–340CrossRefPubMed
7.
Zurück zum Zitat Suzuki H, Kato J, Kuriyama M et al (2010) Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 16:1245–1251CrossRefPubMedPubMedCentral Suzuki H, Kato J, Kuriyama M et al (2010) Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 16:1245–1251CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Dimitroulia E, Spanakis N, Konstantinidou AE et al (2006) Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 12:879–884CrossRefPubMed Dimitroulia E, Spanakis N, Konstantinidou AE et al (2006) Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 12:879–884CrossRefPubMed
9.
Zurück zum Zitat Hommes DW, Sterringa G, van Deventer SJ et al (2004) The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10:245–250CrossRefPubMed Hommes DW, Sterringa G, van Deventer SJ et al (2004) The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10:245–250CrossRefPubMed
10.
Zurück zum Zitat Galiatsatos P, Shrier I, Lamoureux E et al (2005) Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 50:609–616CrossRefPubMed Galiatsatos P, Shrier I, Lamoureux E et al (2005) Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 50:609–616CrossRefPubMed
12.
Zurück zum Zitat Wells GA, Shea B, O’Connell D (2012). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Wells GA, Shea B, O’Connell D (2012). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
13.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed
14.
Zurück zum Zitat Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRef Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRef
15.
Zurück zum Zitat Wada Y, Matsui T, Matake H et al (2003) Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon rectum 46:S59–S65CrossRefPubMed Wada Y, Matsui T, Matake H et al (2003) Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon rectum 46:S59–S65CrossRefPubMed
16.
Zurück zum Zitat Kambham N, Vij R, Cartwright CA et al (2004) Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 28:365–373CrossRefPubMed Kambham N, Vij R, Cartwright CA et al (2004) Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 28:365–373CrossRefPubMed
17.
Zurück zum Zitat Criscuoli V, Casa A, Orlando A et al (2004) Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 36:818–820CrossRefPubMed Criscuoli V, Casa A, Orlando A et al (2004) Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 36:818–820CrossRefPubMed
18.
Zurück zum Zitat Maconi G, Colombo E, Zerbi P et al (2005) Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 37:418–423CrossRefPubMed Maconi G, Colombo E, Zerbi P et al (2005) Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 37:418–423CrossRefPubMed
19.
Zurück zum Zitat Kuwabara A, Okamoto H, Suda T et al (2007) Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 42:823–829CrossRefPubMed Kuwabara A, Okamoto H, Suda T et al (2007) Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 42:823–829CrossRefPubMed
20.
Zurück zum Zitat Li TT, Lv ZS, Wang BM et al (2010) Relationship between refractory ulcerative colitis and cytomegalovirus infection. J World Chin J Dig 18:1174–1177 Li TT, Lv ZS, Wang BM et al (2010) Relationship between refractory ulcerative colitis and cytomegalovirus infection. J World Chin J Dig 18:1174–1177
22.
Zurück zum Zitat Roblin X, Pillet S, Oussalah A, Berthelot P et al (2011) Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 106:2001–2008CrossRefPubMed Roblin X, Pillet S, Oussalah A, Berthelot P et al (2011) Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 106:2001–2008CrossRefPubMed
23.
Zurück zum Zitat Kim YS, Kim YH, Kim JS, Cheon JH, Ye BD, Jung SA, Park YS, Choi CH, Jang BI, Han DS, Yang SK, Kim WH, IBD Study Group of the Korean Association for the Study of Intestinal Diseases (2012) The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol 46(1):51–56. https://doi.org/10.1097/MCG.0b013e3182160c9c CrossRefPubMed Kim YS, Kim YH, Kim JS, Cheon JH, Ye BD, Jung SA, Park YS, Choi CH, Jang BI, Han DS, Yang SK, Kim WH, IBD Study Group of the Korean Association for the Study of Intestinal Diseases (2012) The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol 46(1):51–56. https://​doi.​org/​10.​1097/​MCG.​0b013e3182160c9c​ CrossRefPubMed
24.
Zurück zum Zitat McCurdy JD, Jones A, Enders FT et al (2015) A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 13:131–137CrossRefPubMed McCurdy JD, Jones A, Enders FT et al (2015) A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 13:131–137CrossRefPubMed
25.
Zurück zum Zitat Ormeci AC, Akyuz F, Baran B et al (2016) Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. Eur Rev Med Pharmacol Sci 20:858–865PubMed Ormeci AC, Akyuz F, Baran B et al (2016) Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. Eur Rev Med Pharmacol Sci 20:858–865PubMed
26.
Zurück zum Zitat Lee HS, Park SH, Kim SH, Kim J, Choi J, Lee HJ, Kim WS, Lee JM, Kwak MS, Hwang SW, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH, Yang SK (2016) Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis 22(4):912–918. https://doi.org/10.1097/MIB.0000000000000675 CrossRefPubMed Lee HS, Park SH, Kim SH, Kim J, Choi J, Lee HJ, Kim WS, Lee JM, Kwak MS, Hwang SW, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH, Yang SK (2016) Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis 22(4):912–918. https://​doi.​org/​10.​1097/​MIB.​0000000000000675​ CrossRefPubMed
30.
32.
Zurück zum Zitat Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558–563PubMed Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558–563PubMed
33.
Zurück zum Zitat Delvincourt M, Lopez A, Pillet S et al (2014) The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther 39:712–720CrossRefPubMed Delvincourt M, Lopez A, Pillet S et al (2014) The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther 39:712–720CrossRefPubMed
37.
Zurück zum Zitat Kopylov U, Eliakim-Raz N, Szilagy A et al (2014) Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis. World J Gastroenterol 20:2695–2703CrossRefPubMedPubMedCentral Kopylov U, Eliakim-Raz N, Szilagy A et al (2014) Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis. World J Gastroenterol 20:2695–2703CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Jones A, McCurdy JD, Loftus EVJ et al (2015) Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol 13:949–955CrossRefPubMed Jones A, McCurdy JD, Loftus EVJ et al (2015) Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol 13:949–955CrossRefPubMed
Metadaten
Titel
Cytomegalovirus infection and steroid-refractory inflammatory bowel disease: possible relationship from an updated meta-analysis
verfasst von
Chen-Chen Liu
Shusheng Ji
Yuanyuan Ding
Lili Zhou
Xiangyu Liu
Wen Li
Publikationsdatum
01.02.2018
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2018
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1752-y

Weitere Artikel der Ausgabe 4/2018

Irish Journal of Medical Science (1971 -) 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.